Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06474299 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

The Avenues Study: Dual Use Cessation

StatusRecruiting
PhasePhase 4
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Eligibility criteria expanded, about 14 words
    • Secondary endpoints: details revised at 2 of 2 entries
    • Study description expanded, about 8 words
  2. Eligibility criteria expanded, about 13 words
    • Study description expanded, about 8 words
    v8
  3. Eligibility criteria shortened, about 5 wordsv7
  4. Eligibility criteria expanded, about 11 words
    • Secondary endpoints: details revised at 1 of 2 entries
    v6
  5. Re-verified, no change to tracked fieldsv5
Show 3 earlier versionsHide 3 earlier versions
  1. Start date changed from estimate of Sep 2024 to Sep 24, 2024v4
  2. Trial status: Not Yet Recruiting to Recruiting
    • Site details revised
    v3
  3. Re-verified, no change to tracked fieldsv2
  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The overarching goal of this research is to determine the most effective approach for helping dual users of cigarettes and electronic nicotine delivery systems (ENDS) quit smoking. 500 participants will be enrolled and can expect to be on study for 12 months.
Trial Details
NCT Number NCT06474299
Lead Sponsor University of Wisconsin, Madison
Collaborators: National Cancer Institute (NCI)
Conditions
(from sponsor)		 Smoking Cessation, Electronic Cigarette Use
Related terms Smoking Cessation, Vaping
Enrollment 500 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov